12-14628744-GA-GAA
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_004963.4(GUCY2C):c.2158-8dupT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.52 ( 20634 hom., cov: 0)
Exomes 𝑓: 0.41 ( 83127 hom. )
Consequence
GUCY2C
NM_004963.4 splice_region, intron
NM_004963.4 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.995
Genes affected
GUCY2C (HGNC:4688): (guanylate cyclase 2C) This gene encodes a transmembrane protein that functions as a receptor for endogenous peptides guanylin and uroguanylin, and the heat-stable E. coli enterotoxin. The encoded protein activates the cystic fibrosis transmembrane conductance regulator. Mutations in this gene are associated with familial diarrhea (autosomal dominant) and meconium ileus (autosomal recessive). [provided by RefSeq, Nov 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 12-14628744-G-GA is Benign according to our data. Variant chr12-14628744-G-GA is described in ClinVar as [Benign]. Clinvar id is 402915.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.625 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GUCY2C | NM_004963.4 | c.2158-8dupT | splice_region_variant, intron_variant | ENST00000261170.5 | NP_004954.2 | |||
GUCY2C | XM_011520631.3 | c.1912-8dupT | splice_region_variant, intron_variant | XP_011518933.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GUCY2C | ENST00000261170.5 | c.2158-8dupT | splice_region_variant, intron_variant | 1 | NM_004963.4 | ENSP00000261170.3 |
Frequencies
GnomAD3 genomes AF: 0.516 AC: 77720AN: 150654Hom.: 20588 Cov.: 0
GnomAD3 genomes
AF:
AC:
77720
AN:
150654
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.447 AC: 96986AN: 216742Hom.: 18817 AF XY: 0.439 AC XY: 51764AN XY: 117828
GnomAD3 exomes
AF:
AC:
96986
AN:
216742
Hom.:
AF XY:
AC XY:
51764
AN XY:
117828
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.408 AC: 481838AN: 1181968Hom.: 83127 Cov.: 20 AF XY: 0.409 AC XY: 245394AN XY: 599572
GnomAD4 exome
AF:
AC:
481838
AN:
1181968
Hom.:
Cov.:
20
AF XY:
AC XY:
245394
AN XY:
599572
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.516 AC: 77834AN: 150768Hom.: 20634 Cov.: 0 AF XY: 0.517 AC XY: 37996AN XY: 73550
GnomAD4 genome
AF:
AC:
77834
AN:
150768
Hom.:
Cov.:
0
AF XY:
AC XY:
37996
AN XY:
73550
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 09, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Congenital diarrhea 6 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at